Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Update Il y a 4 ans
Reference: NCT00195715

Woman and Man

Extract

To evaluate the long-term maintenance of response, safety and tolerability of repeated administration of adalimumab in subjects with Crohn's disease who participated in and successfully completed Protocol M02-404 or Protocol M04-691.


Inclusion criteria

  • Crohn’s Disease


Links